Page 32 - Drug Controller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

5642 AIIMS New Delhi chief Randeep Guleria on Sunday said all vaccines licensed by the Indian regulators will be safe Aditi Tandon New Delhi, January 3 AIIMS New Delhi Director Randeep Guleria on Sunday said all vaccines licensed by the Indian regulators will be safe and it is advisable for all to get themselves vaccinated. Guleria, however, said only registered persons can get vaccinated and registrations are currently on only for priority groups of one crore health workers, two crore frontline workers and 27 crore people aged 50 and above and those aged below 50 with co-morbid conditions. ...

Covishield is ready for "roll-out in the coming weeks", said Adar Poonawalla. (File photo) New Delhi: All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India. Mr Poonawalla reiterated that the Covishield vaccine -- developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca - is "safe and effective" against coronavirus and added that the vaccine...

India has followed the U.K. and granted emergency approval for the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford, the first step in its plan to inoculate citizens in the country that’s home to the world’s second-largest Covid-19 outbreak.

Coronavirus Vaccine: Restricted emergency use approval for Serum's Covishield and Bharat Biotech's Covaxin Coronavirus Vaccine: Restricted emergency use approval for Serum's Covishield and Bharat Biotech's Covaxin Mirror Online / Updated: Jan 3, 2021, 12:07 IST Photo by Mahendra Kolhe/MMCL In a two minute statement read out to the media on Sunday morning, India's drug regulatory body announced it has granted emergency restricted use approval to two Covid-19 vaccines. These two are Serum Institute's Covishield and Bharat Biotech's Covaxin. The Drug Controller also announced that it has gran...

Covishield, Covaxin approved Both vaccines to be administered in two doses Can be stored in normal refrigerator New Delhi: It is indeed a red-letter day for India today as two vaccines for COVID-19 produced by Pune-based Serum Institute’s Covishield and Bharat Biotech’s Covaxin, received emergency approval from the country’s drug regulator this morning.  Drug Controller General of India (DCGI) V.G. Somani said both firms submitted data on their trial runs and both have been granted permission for “restricted use.” “We’ll never approve anything if there is slightest of safety c...